After people started testing positive for hepatitis C in a coastal Florida town in December, state officials collected blood from patients, wrapped their specimens in dry ice and mailed them straight to the Centers for Disease Control in Atlanta, Ga.
The scientists at the lab knew what they were doing. Quickly, they analyzed the blood from Florida using their custom software and found that nine cases were genetically linked to the same pain clinic, where it was later discovered that a doctor was improperly reusing injection vials. By March, officials in Florida had restricted the doctor's medical license to limit the spread of the virus and packaged new patient samples to send to the CDC for testing, CDC employees told NPR.
But on April 1, the outbreak investigation was brought to a halt. All 27 of the lab's scientists received an email from the U.S. Department of Health and Human Services informing them that they were losing their jobs.
The email said their duties were "identified as either unnecessary or virtually identical to duties being performed elsewhere in the agency." But the kind of genetic tracing that the CDC's lab performs is not conducted by any other lab in the United States or the world, experts interviewed by NPR said.
While the lab remains shuttered, ongoing investigations of current hepatitis outbreaks have been stalled, not just in Florida, but also in Oregon, Pennsylvania, Massachusetts, New Mexico, Wisconsin, West Virginia and Georgia, according to CDC employees
Epidemiologists still working at the CDC have been trying to find another place that can do the analysis but have been unsuccessful, an agency employee told NPR.
"Commercial laboratories do not do this because it's not profitable," said the employee. "That's why no one really does it except for us."
Used to do it.